Edison, NJ, United States of America

Ioannis N Houpis

This inventor holds 10 USPTO granted patents. Top assignees: Merck + Co., Inc., Other. Active years: 1994-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ioannis N Houpis. Retrieved from https://idiyas.com/inventor/ioannis-n-houpis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 59(Granted Patents)


Location History:

  • Edison, NJ (US) (1994 - 1995)
  • Plainfield, NJ (US) (1995 - 2002)

Company Filing History:


Years Active: 1994-2002

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Ioannis N Houpis: Innovator in Pharmaceutical Chemistry

Introduction

Ioannis N Houpis is a notable inventor based in Edison, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 10 patents, showcasing his innovative approach to solving complex chemical challenges.

Latest Patents

Among his latest patents, Houpis has developed a method for the diastereoselective preparation of Michael adducts. This process involves conducting Michael addition in the presence of a zinc-amine complex, resulting in products with high diastereomeric excess. Additionally, he has created a process for making phenyl heterocycles that are useful as COX-2 inhibitors, which are significant in the treatment of cyclooxygenase-2 mediated diseases.

Career Highlights

Throughout his career, Houpis has worked with prominent companies, including Merck & Company, Inc. His work has significantly impacted the field of medicinal chemistry, particularly in the development of new therapeutic agents.

Collaborations

Houpis has collaborated with notable colleagues such as Ralph P Volante and Audrey Molina, contributing to various innovative projects in the pharmaceutical sector.

Conclusion

Ioannis N Houpis stands out as a significant figure in the realm of pharmaceutical innovations. His patents and collaborations reflect his dedication to advancing medical science through chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…